Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pileri

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
International Journal of Cancer|March 15, 1996
Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and ItalyL Leoncini, D Spina, A Nyong'o, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphomaG Caletti, P L Zinzani, P Fusaroli, et al.
British Journal of Haematology|March 1, 1996
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID miceA Terenzi, A Bolognesi, L Pasqualucci, et al.
Blood|February 13, 2001
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin diseaseL Teofili, A L Di Febo, F Pierconti, et al.
American Journal of Hematology|December 12, 1997
Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomasG Gaidano, G Volpe, C Pastore, et al.
International Journal of Cancer|September 2, 1999
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysisL Leoncini, A Cossu, T Megha, et al.
Blood|April 16, 1998
ALK-positive lymphoma: a single disease with a broad spectrum of morphologyD Benharroch, Z Meguerian-Bedoyan, L Lamant, et al.
Current Cancer Drug Targets|June 29, 2010
Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-conceptC Falciani, B Lelli, J Brunetti, et al.
International Journal of Cancer|July 15, 1998
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1L Leoncini, T Megha, S Lazzi, et al.
The American Journal of Pathology|December 1, 1996
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissuesM Gambacorta, L Flenghi, M Fagioli, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
International Journal of Cancer|March 15, 1996
Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and ItalyL Leoncini, D Spina, A Nyong'o, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphomaG Caletti, P L Zinzani, P Fusaroli, et al.
British Journal of Haematology|March 1, 1996
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID miceA Terenzi, A Bolognesi, L Pasqualucci, et al.
Blood|February 13, 2001
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin diseaseL Teofili, A L Di Febo, F Pierconti, et al.
American Journal of Hematology|December 12, 1997
Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomasG Gaidano, G Volpe, C Pastore, et al.
International Journal of Cancer|September 2, 1999
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysisL Leoncini, A Cossu, T Megha, et al.
Blood|April 16, 1998
ALK-positive lymphoma: a single disease with a broad spectrum of morphologyD Benharroch, Z Meguerian-Bedoyan, L Lamant, et al.
Current Cancer Drug Targets|June 29, 2010
Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-conceptC Falciani, B Lelli, J Brunetti, et al.
International Journal of Cancer|July 15, 1998
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1L Leoncini, T Megha, S Lazzi, et al.
The American Journal of Pathology|December 1, 1996
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissuesM Gambacorta, L Flenghi, M Fagioli, et al.
Pageof 25